At UNSW Sydney, researchers wielding the molecular precision of CRISPR have uncovered why a rare few born with sickle cell disease never suffer its cruelties — a single small deletion in the genome quietly keeps a protective fetal protein switched on for life. The discovery, emerging from the genomes of naturally protected patients and confirmed in laboratory cell lines, offers not merely an answer to a decades-old mystery but a potential map toward therapies for the 318,000 infants born each year into this inherited burden. In finding one unified mechanism where many had assumed chaos, scienc
News-Medical.net
· Apr 09, 2022
· health
· 4 min read
High
Sourcing: Verified
UNSW researchers use CRISPR to unlock sickle cell disease mechanism
Sickle cell disease and beta thalassemia cause 3% of deaths in children under five worldwide, with over 318,000 infants born annually with these conditions.
◉
Science & Space
6989 related articles
NASA Launches Artemis II: Four Astronauts Head to Moon in Historic Mis…
Devdiscourse · 100% match
NASA study finds Earth microbes could survive on Moon's South Pole, co…
Texas Public Radio | TPR · 99% match
Blue Origin Probed Over Rocket Failure as Mars Rover Finds Organic Com…
Devdiscourse · 99% match
Israeli radiation vest shows promise for safer deep-space missions
jns.org · 99% match
Starship's Raw Power Masks Mars Challenge: Orbital Refueling Still Unp…
Space Daily · 99% match
Related Coverage
Science Daily · Aug 24
Trump to Honor Artemis II Astronauts With Congressional Space Medal
President Trump will award the Congressional Space Medal of Honor to the Artemis II crew for completing a historic 10-da…
News-Medical · Aug 24 Decade-long Scottish study finds screen time's effects on child development far more complex than fearedA Scottish longitudinal study tracking 3,786 children from ages 5-15 found screen use showed limited and inconsistent as…
Education News Canada · Aug 24 UNB researchers help confirm first evidence of elemental sulfur on MarsUniversity of New Brunswick researchers contributed to the first confirmed discovery of elemental sulfur on Mars, sugges…
South China Morning Post · Aug 24 Chinese researchers develop compact X-ray camera for real-time medical imaging with lower radiationA Chinese research team has created a tabletop X-ray camera that captures dynamic medical imaging with lower radiation d…
Bias & Framing
No detailed analysis data available for this lens. Try re-running lenses from the admin panel.
Geopolitical Impact
🌎
UNSW CRISPR research advances sickle cell disease understanding with therapeutic implications, primarily benefiting medical science rather than geopolitical dynamics.
Escalation Risk
low
Confidence
HIGH
No significant geopolitical power shifts. This is biomedical research with potential humanitarian benefits, particularly for tropical regions with high disease prevalence. Australia-US scientific collaboration continues existing research partnerships.
Economic Lens
📈
UNSW CRISPR research identifies genetic mechanism in sickle cell disease, potentially enabling new therapeutics and supporting biotech sector growth in gene editing and rare disease treatment.
Market Signal
bullish
Confidence
MED
Biotechnology and gene therapy
Pharmaceutical and drug development
Healthcare and medical devices
Research and development
Rare disease treatment
Patients with sickle cell disease and beta thalassemia may eventually access more effective treatments, reducing healthcare costs and improving quality of life. Broader population benefits from advancing gene-editing technology applications.
Governments may increase funding for rare disease research and gene therapy development. Regulatory frameworks for CRISPR-based therapeutics will likely evolve. Patent and IP protections for gene-editing innovations may be strengthened. Healthcare systems may need to prepare for potential high-cost gene therapies.